The U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death.
- Read more about FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/fda-authorizes-second-booster-dose-of-two-covid-19-vaccines-for-older-and-immunocompromised-individuals
No comments:
Post a Comment